385 related articles for article (PubMed ID: 15639117)
1. Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial.
Klinge L; Straub V; Neudorf U; Schaper J; Bosbach T; Görlinger K; Wallot M; Richards S; Voit T
Neuromuscul Disord; 2005 Jan; 15(1):24-31. PubMed ID: 15639117
[TBL] [Abstract][Full Text] [Related]
2. Enzyme replacement therapy in classical infantile pompe disease: results of a ten-month follow-up study.
Klinge L; Straub V; Neudorf U; Voit T
Neuropediatrics; 2005 Feb; 36(1):6-11. PubMed ID: 15776317
[TBL] [Abstract][Full Text] [Related]
3. Long-term enzyme replacement therapy for pompe disease with recombinant human alpha-glucosidase derived from chinese hamster ovary cells.
Rossi M; Parenti G; Della Casa R; Romano A; Mansi G; Agovino T; Rosapepe F; Vosa C; Del Giudice E; Andria G
J Child Neurol; 2007 May; 22(5):565-73. PubMed ID: 17690063
[TBL] [Abstract][Full Text] [Related]
4. Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.
Raben N; Fukuda T; Gilbert AL; de Jong D; Thurberg BL; Mattaliano RJ; Meikle P; Hopwood JJ; Nagashima K; Nagaraju K; Plotz PH
Mol Ther; 2005 Jan; 11(1):48-56. PubMed ID: 15585405
[TBL] [Abstract][Full Text] [Related]
5. Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy.
Winkel LP; Kamphoven JH; van den Hout HJ; Severijnen LA; van Doorn PA; Reuser AJ; van der Ploeg AT
Muscle Nerve; 2003 Jun; 27(6):743-51. PubMed ID: 12766987
[TBL] [Abstract][Full Text] [Related]
6. Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy.
Katzin LW; Amato AA
J Clin Neuromuscul Dis; 2008 Jun; 9(4):421-31. PubMed ID: 18525427
[TBL] [Abstract][Full Text] [Related]
7. Cardiac arrhythmias following anesthesia induction in infantile-onset Pompe disease: a case series.
Wang LY; Ross AK; Li JS; Dearmey SM; Mackey JF; Worden M; Corzo D; Morgan C; Kishnani PS
Paediatr Anaesth; 2007 Aug; 17(8):738-48. PubMed ID: 17596219
[TBL] [Abstract][Full Text] [Related]
8. Complete correction of acid alpha-glucosidase deficiency in Pompe disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeletal muscle.
Pauly DF; Johns DC; Matelis LA; Lawrence JH; Byrne BJ; Kessler PD
Gene Ther; 1998 Apr; 5(4):473-80. PubMed ID: 9614571
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronidase increases the biodistribution of acid alpha-1,4 glucosidase in the muscle of Pompe disease mice: an approach to enhance the efficacy of enzyme replacement therapy.
Matalon R; Surendran S; Campbell GA; Michals-Matalon K; Tyring SK; Grady J; Cheng S; Kaye E
Biochem Biophys Res Commun; 2006 Nov; 350(3):783-7. PubMed ID: 17027913
[TBL] [Abstract][Full Text] [Related]
10. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up.
Winkel LP; Van den Hout JM; Kamphoven JH; Disseldorp JA; Remmerswaal M; Arts WF; Loonen MC; Vulto AG; Van Doorn PA; De Jong G; Hop W; Smit GP; Shapira SK; Boer MA; van Diggelen OP; Reuser AJ; Van der Ploeg AT
Ann Neurol; 2004 Apr; 55(4):495-502. PubMed ID: 15048888
[TBL] [Abstract][Full Text] [Related]
11. [Adult form of Pompe disease].
Ziółkowska-Graca B; Kania A; Zwolińska G; Nizankowska-Mogilnicka E
Pneumonol Alergol Pol; 2008; 76(5):396-9. PubMed ID: 19003770
[TBL] [Abstract][Full Text] [Related]
12. Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease.
Kishnani PS; Nicolino M; Voit T; Rogers RC; Tsai AC; Waterson J; Herman GE; Amalfitano A; Thurberg BL; Richards S; Davison M; Corzo D; Chen YT
J Pediatr; 2006 Jul; 149(1):89-97. PubMed ID: 16860134
[TBL] [Abstract][Full Text] [Related]
13. Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk.
Van den Hout JM; Kamphoven JH; Winkel LP; Arts WF; De Klerk JB; Loonen MC; Vulto AG; Cromme-Dijkhuis A; Weisglas-Kuperus N; Hop W; Van Hirtum H; Van Diggelen OP; Boer M; Kroos MA; Van Doorn PA; Van der Voort E; Sibbles B; Van Corven EJ; Brakenhoff JP; Van Hove J; Smeitink JA; de Jong G; Reuser AJ; Van der Ploeg AT
Pediatrics; 2004 May; 113(5):e448-57. PubMed ID: 15121988
[TBL] [Abstract][Full Text] [Related]
14. Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy.
van der Beek NA; Hagemans ML; van der Ploeg AT; Reuser AJ; van Doorn PA
Acta Neurol Belg; 2006 Jun; 106(2):82-6. PubMed ID: 16898258
[TBL] [Abstract][Full Text] [Related]
15. Enzyme replacement therapy in severe adult-onset glycogen storage disease type II.
Ravaglia S; Danesino C; Pichiecchio A; Repetto A; Poloni GU; Rossi M; Fratino P; Moglia A; Costa A
Adv Ther; 2008 Aug; 25(8):820-9. PubMed ID: 18704279
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease.
Orlikowski D; Pellegrini N; Prigent H; Laforêt P; Carlier R; Carlier P; Eymard B; Lofaso F; Annane D
Neuromuscul Disord; 2011 Jul; 21(7):477-82. PubMed ID: 21550241
[TBL] [Abstract][Full Text] [Related]
17. Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk.
Van den Hout JM; Reuser AJ; de Klerk JB; Arts WF; Smeitink JA; Van der Ploeg AT
J Inherit Metab Dis; 2001 Apr; 24(2):266-74. PubMed ID: 11405345
[TBL] [Abstract][Full Text] [Related]
18. Infantile-onset Pompe disease: a diagnosis not to miss.
Dixon CA; Anderson JB; Ruddy RM; Cripe LH
Pediatr Emerg Care; 2010 Apr; 26(4):293-5. PubMed ID: 20386415
[TBL] [Abstract][Full Text] [Related]
19. Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease.
Hunley TE; Corzo D; Dudek M; Kishnani P; Amalfitano A; Chen YT; Richards SM; Phillips JA; Fogo AB; Tiller GE
Pediatrics; 2004 Oct; 114(4):e532-5. PubMed ID: 15466083
[TBL] [Abstract][Full Text] [Related]
20. [A retrospective study of six patients with late-onset Pompe disease].
Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]